CRUK researchers develop new early-stage rectal cancer treatment
New treatment could prevent debilitating side effects of standard major surgery
11th December 2020
Latest news
Alunbrig scores NICE backing for ALK-positive lung cancer
ALK inhibitor recommended in the first-line non-small cell lung cancer setting
11th December 2020
Sanofi, GSK face COVID-19 vaccine trial delay
Potential availability of vaccine now delayed to the end of 2021
11th December 2020
Crescendo Biologics expands Takeda collaboration
Follows previous agreements signed in November 2018 and July 2019
10th December 2020
FDA set to review GSK’s Nucala for nasal polyps
Submission is based on data from the pivotal SYNAPSE study
10th December 2020
Enhertu scores ‘impressive’ new data in HER2 breast cancer
Updated data from DESTINY-Breast01 trial continues to demonstrate efficacy
10th December 2020
MHRA issues allergy warning for Pfizer/BioNTech COVID-19 jab
Updated guidance warns people with a history of allergic reactions not to receive the shot
10th December 2020
Kite’s CAR T therapy Yescarta shows potential in new indication
ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma
9th December 2020
Pfizer’s pneumococcal disease vaccine scores FDA priority review
Vaccine candidate previously scored fast-track and breakthrough therapy designations
9th December 2020
Novartis signs AI ophthalmology pact with RetinAI
Agreement will utilise RetinAI's IT solutions and artificial intelligence tools to support projects in ophthalmology
9th December 2020
Winners shine bright at PharmaTimes Awards
Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards
9th December 2020
Roche reveals new bispecific antibody data in blood cancers
'Encouraging' data for investigational candidates across a range of blood cancers
9th December 2020
NICE backs AZ' Calquence for chronic lymphocytic leukaemia
The recommendations are positive for a select population of patients with CLL
8th December 2020
Two medicines accepted for use by NHS Scotland
Medicines for blood cancer and a rare muscle disorder will be made available for NHS patients
8th December 2020
CR UK makes further cuts in COVID's wake
The charity is slashing £45 million from its research budget
8th December 2020
